Are the Point-of-Care Diagnostics MULTIPLATE and ROTEM Valid in the Setting of High Concentrations of Heparin and Its Reversal With Protamine?
- 31 December 2011
- journal article
- clinical trial
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 25 (6) , 981-986
- https://doi.org/10.1053/j.jvca.2010.11.020
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot studyBritish Journal of Anaesthesia, 2009
- The TEG® vs the ROTEM® thromboelastography/thromboelastometry systemsAnaesthesia, 2009
- Low Plasma Fibrinogen Levels with the Clauss Method during Anticoagulation with BivalirudinAnesthesiology, 2008
- Improved Clot Formation by Combined Administration of Activated Factor VII (NovoSeven®) and Fibrinogen (Haemocomplettan® P)Anesthesia & Analgesia, 2008
- Variables influencing Multiplate™ whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individualsPlatelets, 2007
- Protamine Enhances Fibrinolysis by Decreasing Clot Strength: Role of Tissue Factor-Initiated Thrombin GenerationThe Annals of Thoracic Surgery, 2006
- In patients post cardiac surgery do high doses of protamine cause increased bleeding?Interactive CardioVascular and Thoracic Surgery, 2003
- Effects of Unfractionated Heparin, Low-Molecular-Weight Heparin, and Heparinoid on Thromboelastographic Assay of Blood CoagulationAmerican Journal of Clinical Pathology, 2000
- Protamine Reversal of Heparin Affects Platelet Aggregation and Activated Clotting Time After Cardiopulmonary BypassAnesthesia & Analgesia, 1998
- Interaction of protamine sulfate with thrombinAmerican Journal of Hematology, 1983